HEADER VIRAL PROTEIN/IMMUNE SYSTEM 03-OCT-10 2XT1 TITLE CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN (146- TITLE 2 231) IN COMPLEX WITH A CAMELID VHH. COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAG POLYPROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, RESIDUES 146-231; COMPND 5 SYNONYM: HIV-1 CAPSID PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMELID VHH 9; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 STRAIN: NL4-3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VARIANT: CODONPLUS-RIL; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET11C; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: VICUGNA PACOS; SOURCE 14 ORGANISM_COMMON: ALPACA; SOURCE 15 ORGANISM_TAXID: 30538; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.IGONET,M.C.VANEY,V.BARTONOVA,J.HELMA,U.ROTHBAUER,H.LEONHARDT, AUTHOR 2 E.STURA,H.-G.KRAUSSLICH,F.A.REY REVDAT 4 20-DEC-23 2XT1 1 REMARK REVDAT 3 14-AUG-19 2XT1 1 AUTHOR JRNL REVDAT 2 20-JUN-18 2XT1 1 LINK REVDAT 1 12-OCT-11 2XT1 0 JRNL AUTH S.IGONET,M.C.VANEY,V.BARTONOVA,J.HELMA,U.ROTHBAUER, JRNL AUTH 2 H.LEONHARDT,E.STURA,H.-G.KRAUSSLICH,F.A.REY JRNL TITL TARGETING HIV-1 VIRION FORMATION WITH NANOBODIES JRNL TITL 2 -IMPLICATIONS FOR THE DESIGN OF ASSEMBLY INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 44606 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2258 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.32 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.42 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2689 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2234 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2561 REMARK 3 BIN R VALUE (WORKING SET) : 0.2241 REMARK 3 BIN FREE R VALUE : 0.2098 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.76 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 128 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1521 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 271 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.73940 REMARK 3 B22 (A**2) : -1.03690 REMARK 3 B33 (A**2) : 0.29750 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.129 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.052 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.053 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.048 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.050 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1626 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2206 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 582 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 42 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 243 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1626 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 209 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2132 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.05 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.88 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE 6XHISTIDINE TAG AT THE C-TERMINAL REMARK 3 END OF CHAIN B IS DISORDERED. REMARK 4 REMARK 4 2XT1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1290045542. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 5 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9395 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45032 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.320 REMARK 200 RESOLUTION RANGE LOW (A) : 44.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.100 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 13.70 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRIES 2BUO, 1KXV REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28-32 % W/V PEG 4000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 30.03000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.08500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.03000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.08500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 60.06000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2017 LIES ON A SPECIAL POSITION. REMARK 375 HOH B2087 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B -1 REMARK 465 HIS B 114 REMARK 465 HIS B 115 REMARK 465 HIS B 116 REMARK 465 HIS B 117 REMARK 465 HIS B 118 REMARK 465 HIS B 119 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 146 N - CA - C ANGL. DEV. = 16.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 1 -66.54 -24.56 REMARK 500 ALA B 88 168.59 179.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1232 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1114 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2XXM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C- TERMINAL DOMAIN IN REMARK 900 COMPLEX WITH A CAMELID VHH AND THE CAI PEPTIDE. REMARK 900 RELATED ID: 2XXC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A CAMELID VHH RAISED AGAINST THE HIV-1 CAPSID REMARK 900 PROTEIN C-TERMINAL DOMAIN. REMARK 900 RELATED ID: 2XV6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C- TERMINAL DOMAIN REMARK 900 (146-220) IN COMPLEX WITH A CAMELID VHH. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE VHH RESIDUES (CHAIN B) ARE NUMBERED ACCORDING TO THE REMARK 999 KABAT NUMBERING. DBREF 2XT1 A 146 231 UNP Q71B32 Q71B32_9HIV1 146 231 DBREF 2XT1 B -1 113 PDB 2XT1 2XT1 -1 113 SEQADV 2XT1 GLY A 208 UNP Q71B32 ALA 208 CONFLICT SEQRES 1 A 86 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 A 86 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 A 86 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ASN TRP SEQRES 4 A 86 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 A 86 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 A 86 LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL GLY GLY SEQRES 7 A 86 PRO GLY HIS LYS ALA ARG VAL LEU SEQRES 1 B 121 MET ALA GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU SEQRES 2 B 121 VAL GLN ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SEQRES 3 B 121 SER GLY SER PHE PHE MET SER ASN VAL MET ALA TRP TYR SEQRES 4 B 121 ARG GLN ALA PRO GLY LYS ALA ARG GLU LEU ILE ALA ALA SEQRES 5 B 121 ILE ARG GLY GLY ASP MET SER THR VAL TYR ASP ASP SER SEQRES 6 B 121 VAL LYS GLY ARG PHE THR ILE THR ARG ASP ASP ASP LYS SEQRES 7 B 121 ASN ILE LEU TYR LEU GLN MET ASN ASP LEU LYS PRO GLU SEQRES 8 B 121 ASP THR ALA MET TYR TYR CYS LYS ALA SER GLY SER SER SEQRES 9 B 121 TRP GLY GLN GLY THR GLN VAL THR VAL SER SER HIS HIS SEQRES 10 B 121 HIS HIS HIS HIS HET GOL A1232 6 HET GOL B1114 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 HOH *271(H2 O) HELIX 1 1 SER A 149 ILE A 153 5 5 HELIX 2 2 PRO A 160 GLU A 175 1 16 HELIX 3 3 SER A 178 LEU A 190 1 13 HELIX 4 4 ASN A 195 GLY A 206 1 12 HELIX 5 5 THR A 210 GLN A 219 1 10 HELIX 6 6 ASP B 61 LYS B 64 5 4 HELIX 7 7 LYS B 83 THR B 87 5 5 SHEET 1 BA 4 GLN B 3 SER B 7 0 SHEET 2 BA 4 LEU B 18 SER B 25 -1 O SER B 21 N SER B 7 SHEET 3 BA 4 ILE B 77 MET B 82 -1 O LEU B 78 N CYS B 22 SHEET 4 BA 4 PHE B 67 ASP B 72 -1 O THR B 68 N GLN B 81 SHEET 1 BB 6 GLY B 10 GLN B 13 0 SHEET 2 BB 6 THR B 107 SER B 112 1 O GLN B 108 N GLY B 10 SHEET 3 BB 6 ALA B 88 ALA B 94 -1 O ALA B 88 N VAL B 109 SHEET 4 BB 6 VAL B 33 GLN B 39 -1 O ALA B 35 N LYS B 93 SHEET 5 BB 6 GLU B 46 ARG B 52 -1 O GLU B 46 N ARG B 38 SHEET 6 BB 6 THR B 57 TYR B 59 -1 O VAL B 58 N ALA B 50 SSBOND 1 CYS B 22 CYS B 92 1555 1555 1.99 CISPEP 1 SER A 146 PRO A 147 0 -1.10 SITE 1 AC1 7 LEU A 202 GLY A 206 PRO A 207 GLY A 208 SITE 2 AC1 7 ALA A 209 LEU A 231 HOH A2090 SITE 1 AC2 7 TYR B 59 LYS B 64 GLY B 65 ARG B 66 SITE 2 AC2 7 PHE B 67 THR B 68 HOH B2141 CRYST1 60.060 88.170 35.660 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016650 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011342 0.000000 0.00000 SCALE3 0.000000 0.000000 0.028043 0.00000